These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34063519)

  • 1. Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation.
    Sun Q; Levy RM; Kirby KA; Wang Z; Sarafianos SG; Deng N
    Viruses; 2021 May; 13(5):. PubMed ID: 34063519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
    Price AJ; Jacques DA; McEwan WA; Fletcher AJ; Essig S; Chin JW; Halambage UD; Aiken C; James LC
    PLoS Pathog; 2014 Oct; 10(10):e1004459. PubMed ID: 25356722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
    Siddiqui MA; Saito A; Halambage UD; Ferhadian D; Fischer DK; Francis AC; Melikyan GB; Ambrose Z; Aiken C; Yamashita M
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
    Marcelin AG; Charpentier C; Jary A; Perrier M; Margot N; Callebaut C; Calvez V; Descamps D
    J Antimicrob Chemother; 2020 Jun; 75(6):1588-1590. PubMed ID: 32154864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir.
    Bester SM; Adu-Ampratwum D; Annamalai AS; Wei G; Briganti L; Murphy BC; Haney R; Fuchs JR; Kvaratskhelia M
    mBio; 2022 Oct; 13(5):e0180422. PubMed ID: 36190128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
    Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
    J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
    Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.
    Nka AD; Bouba Y; Teto G; Semengue ENJ; Takou DK; Ngueko AMK; Fabeni L; Carioti L; Armenia D; Pabo W; Dambaya B; Sosso SM; Colizzi V; Perno CF; Ceccherini-Silberstein F; Santoro MM; Fokam J; Ndjolo A
    J Antimicrob Chemother; 2022 Dec; 78(1):272-275. PubMed ID: 36411257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid.
    Smaga SS; Xu C; Summers BJ; Digianantonio KM; Perilla JR; Xiong Y
    Structure; 2019 Aug; 27(8):1234-1245.e5. PubMed ID: 31155311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of HIV-1 capsid interaction with the restriction factor TRIM5α identified by magic-angle spinning NMR and molecular dynamics simulations.
    Quinn CM; Wang M; Fritz MP; Runge B; Ahn J; Xu C; Perilla JR; Gronenborn AM; Polenova T
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11519-11524. PubMed ID: 30333189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical targeting of HIV capsid protein with a long-acting small molecule.
    Link JO; Rhee MS; Tse WC; Zheng J; Somoza JR; Rowe W; Begley R; Chiu A; Mulato A; Hansen D; Singer E; Tsai LK; Bam RA; Chou CH; Canales E; Brizgys G; Zhang JR; Li J; Graupe M; Morganelli P; Liu Q; Wu Q; Halcomb RL; Saito RD; Schroeder SD; Lazerwith SE; Bondy S; Jin D; Hung M; Novikov N; Liu X; Villaseñor AG; Cannizzaro CE; Hu EY; Anderson RL; Appleby TC; Lu B; Mwangi J; Liclican A; Niedziela-Majka A; Papalia GA; Wong MH; Leavitt SA; Xu Y; Koditek D; Stepan GJ; Yu H; Pagratis N; Clancy S; Ahmadyar S; Cai TZ; Sellers S; Wolckenhauer SA; Ling J; Callebaut C; Margot N; Ram RR; Liu YP; Hyland R; Sinclair GI; Ruane PJ; Crofoot GE; McDonald CK; Brainard DM; Lad L; Swaminathan S; Sundquist WI; Sakowicz R; Chester AE; Lee WE; Daar ES; Yant SR; Cihlar T
    Nature; 2020 Aug; 584(7822):614-618. PubMed ID: 32612233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G; Steinbrecher T; Papadopoulos MG
    J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.
    Balasubramaniam M; Zhou J; Addai A; Martinez P; Pandhare J; Aiken C; Dash C
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.
    Gallay PA; Ptak RG; Bobardt MD; Dumont JM; Vuagniaux G; Rosenwirth B
    Viruses; 2013 Mar; 5(3):981-97. PubMed ID: 23524389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.